FibroBiologics, Inc. (FBLG)
Nasdaq: FBLG · Pharmaceutical Preparations · Houston, TX · filing with the SEC since 2023
Filings
185 filings since 2017 beside 57 insider forms · and emerging growth company · read from EDGAR on Nov 13, 2026Due next and emerging growth company
10-Q
Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by Nov 14, 2026
10-K
Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Jul 31, 2026.
Filings a yearinsider forms included
20896469
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 10 times in the last 36 months, the newest Aug 24, 2026.Listing warning from its exchange (8-K item 3.01): 5 times in the last 36 months, the newest Jul 24, 2026.SEC letters: 20 in the last 36 months, the newest Mar 27, 2026.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Oct 8, 2026
8-K items 1.01, 2.03, 3.02, 9.01
Major agreement signed; New debt or obligation taken on; Shares sold without registration · Current report
Oct 7, 2026
Sep 18, 2026
8-K items 5.07, 7.01, 9.01
Shareholder vote; Investor disclosure (Regulation FD) · Current report
Sep 17, 2026
Sep 15, 2026
8-K items 1.01, 3.02, 9.01
Major agreement signed; Shares sold without registration · Current report
Aug 24, 2026
8-K items 5.02, 7.01, 9.01
Officer or director change; Investor disclosure (Regulation FD) · Current report
Aug 20, 2026
Jul 9, 2026
8-K items 5.02, 7.01, 9.01
Officer or director change; Investor disclosure (Regulation FD) · Current report
Jul 2, 2026
Jun 29, 2026
8-K items 1.01, 3.02, 7.01, 9.01
Major agreement signed; Shares sold without registration; Investor disclosure (Regulation FD) · Current report
Jun 25, 2026
Jun 23, 2026
8-K items 5.02, 5.07, 9.01
Officer or director change; Shareholder vote · Current report
Jun 22, 2026
Apr 20, 2026
8-K items 7.01, 8.01, 9.01
Investor disclosure (Regulation FD); Other event · Current report
Mar 9, 2026
Apr 17, 2026
8-K items 5.03, 9.01
Charter, bylaw or fiscal-year change · Current report
Apr 16, 2026
Apr 9, 2026
8-K/A items 1.01, 1.02, 8.01, 9.01
Major agreement signed; Major agreement ended; Other event · Current report, amended
Apr 3, 2026
Apr 9, 2026
8-K items 1.01, 8.01, 9.01
Major agreement signed; Other event · Current report
Apr 3, 2026
Apr 3, 2026
8-K items 3.03, 5.03, 9.01
Change to shareholders' rights; Charter, bylaw or fiscal-year change · Current report
Mar 30, 2026
40 of 185 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.